Sen. James M. Inhofe sold Johnson & Johnson (JNJ)
Sen. James M. Inhofe (R-OK) · $50K–$100K · traded Jun 9, 2017
- Transaction
- Sold (full)
- Amount
- $50K–$100K
- Owner
- The member
- Traded
- Jun 9, 2017
- Disclosed
- Jul 3, 2017
- Days to disclose
- 24
- Asset type
- Stock
- As filed
- Johnson & Johnson
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
- Jul 3, 2017$50K–$100K
$50K–$100K · Traded Jun 26, 2017 · disclosed Jul 3, 2017
- Jul 3, 2017$15K–$50K
Sold (full) Corgi ETF Trust I - Corgi NFLX 2x Daily ETF NFX
$15K–$50K · Traded Jun 26, 2017 · disclosed Jul 3, 2017
- Jul 3, 2017$50K–$100K
Bought Sensata Technologies Holding ST
$50K–$100K · Traded Jun 19, 2017 · disclosed Jul 3, 2017
- Jul 3, 2017$50K–$100K
$50K–$100K · Traded Jun 19, 2017 · disclosed Jul 3, 2017
- Jul 3, 2017$50K–$100K
$50K–$100K · Traded Jun 9, 2017 · disclosed Jul 3, 2017
Recent Congress trades in JNJ
- Oct 30, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold (partial) Johnson & Johnson JNJ
$1K–$15K · Traded Sep 30, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and Commerce - Oct 9, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 9, 2026 · Spouse
- Oct 9, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Sep 4, 2026 · disclosed Oct 9, 2026 · Spouse
- Oct 6, 2026$1K–$15K
Rep. Lloyd Doggett (D-TX-37)
$1K–$15K · Traded Sep 8, 2026 · disclosed Oct 6, 2026
- Sep 14, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
$1K–$15K · Traded Aug 27, 2026 · disclosed Sep 14, 2026
Committee overlap: Energy and Commerce - Sep 11, 2026$1K–$15K
Sen. John Boozman (R-AR)
Sold (partial) Johnson & Johnson JNJ
$1K–$15K · Traded Aug 20, 2026 · disclosed Sep 11, 2026 · Joint
- Sep 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Aug 7, 2026 · disclosed Sep 7, 2026 · Dependent
- Aug 17, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 17, 2026
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.